Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Single Dose Study To Explore The Safety, Pharmacokinetics And Pharmacodynamics Of PHA-794428 In Pediatric Patients With Growth Hormone Deficiency

NCT00314938 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00314938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00314938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Single Dose Study To Explore The Safety, Pharmacokinetics And Pharmacodynamics Of PHA-794428 In Pediatric Patients With Growth Hormone Deficiency
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2006
Completion date
November 30, 2007
Enrollment
32
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency